Abstract
Lincomycin derives its name from Lincoln, Nebraska. The antibiotic was isolated from a soil organism Streptomyces lincolnensis found in this area and it was first introduced in 1963. Lincomycin differs chemically from most other available antibiotics. One of its derivatives, 7-chloro-7-deoxy-lincomycin, now known as clindamycin, is superior in antibacterial activity and is also better absorbed following oral administration.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Cohen, L.E.; McNeill, C.J. and Wells, R.F.: Clindamycin associated colitis. Journal of the American Medical Association 223: 1379–1380 (1973).
Garrod, L.P.; Lambert, H.P. and O’Grady, F.: Lincomycin; in Antibiotic and Chemotherapy, 4th ed, p.208 and 212 (Churchill Livingstone, Edinburgh and London 1973).
Geddes, A.M.; Sleet, R.A. and Murdoch, J. McC.: Lincomycin. Hydrochloride: Clinical and laboratory studies. British Medical Journal 2: 660–664 (1964).
Geddes, A.M.; Dwyer, N. St. J.; Ball, A.P. and Amos, R.S.: Clindamycin in bone and joint infections. Journal of Antimicrobial Chemotherapy 3: 501–507 (1977).
Kaplan, K. and Weinstein, L.: Lincomycin. Pediatric Clinics of North America 15: 131–139 (1968).
McGehee, R.F.; Smith, C.B.; Wilcox, C. and Finland, M.: Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. American Journal of Medical Sciences 256: 279–292 (1968).
Novak, E.; Vitti, T.G.; Panzer, J.D.; Schlagel, C. and Hearron, M.S.: Antibiotic tolerance and serum levels after intravenous administration of multiple large doses of lincomycin. Clinical Pharmacology and Therapeutics 12: 793–797 (1971).
Phillips, I.; Fernandes, R. and Warren, Christine: In vitro comparison of erythromycin, lincomycin and clindamycin. British Medical Journal 2: 89 (1970).
Pittman, F.E.; Pittman, J.C. and Humphrey, C.D.: Lincomycin and pseudomembranous colitis. Lancet 1: 451–452(1974).
Sanders, E.: Lincomycin: Fact, fantasy and future. Medical Clinics of North America 54: 1295–1303 (1970).
Scott, A.J.; Nicholson, G.I. and Kerr, A.R.: Lincomycin as a cause of pseudomembranous colitis. Lancet 2: 1232–1234(1973).
Wagner, J.G.; Novak, E.; Patel, N.C.; Chidester, C.G. and Lummis, W.L.: Absorption, excretion and half-life of clinimycin in normal adult males. American Journal of Medical Sciences 256: 25–37 (1968).
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1978 ADIS Press
About this chapter
Cite this chapter
Ball, A.P., Gray, J.A., Murdoch, J.M. (1978). Lincomycin and Clindamycin. In: Antibacterial Drugs Today. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-8004-7_10
Download citation
DOI: https://doi.org/10.1007/978-94-011-8004-7_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-85200-505-7
Online ISBN: 978-94-011-8004-7
eBook Packages: Springer Book Archive